fxiia inhibitory antibody (3f7 (CSL Limited)
90
Structured Review
CSL Limited
fxiia inhibitory antibody (3f7
Fxiia Inhibitory Antibody (3f7, supplied by CSL Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fxiia+inhibitory+antibody+(3f7/fxiia+inhibitory+antibody/pmc04563738-368-39-43
Average 90 stars, based on 1 article reviews
Fxiia Inhibitory Antibody (3f7, supplied by CSL Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fxiia+inhibitory+antibody+(3f7/fxiia+inhibitory+antibody/pmc04563738-368-39-43
Average 90 stars, based on 1 article reviews
fxiia inhibitory antibody (3f7 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III Article Snippet: .. Human citrated platelet-poor plasma samples were activated with increasing concentrations (ranging from 1 pg/ml to 100 μg/ml) of high molecular weight DXS (500 kDa, Sigma-Aldrich) or buffer in the presence or absence of C1INH concentrate (Berinert, CSL Behring GmbH); Article Title: Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III Article Snippet: .. Human citrated platelet-poor plasma samples were activated with increasing concentrations (ranging from 1 pg/ml to 100 μg/ml) of high molecular weight DXS (500 kDa, Sigma-Aldrich) or buffer in the presence or absence of C1INH concentrate (Berinert, CSL Behring GmbH); High Molecular Weight:Article Title: Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III Article Snippet: .. Human citrated platelet-poor plasma samples were activated with increasing concentrations (ranging from 1 pg/ml to 100 μg/ml) of high molecular weight DXS (500 kDa, Sigma-Aldrich) or buffer in the presence or absence of C1INH concentrate (Berinert, CSL Behring GmbH); Article Title: Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III Article Snippet: .. Human citrated platelet-poor plasma samples were activated with increasing concentrations (ranging from 1 pg/ml to 100 μg/ml) of high molecular weight DXS (500 kDa, Sigma-Aldrich) or buffer in the presence or absence of C1INH concentrate (Berinert, CSL Behring GmbH); Purification:Article Title: Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection Article Snippet: Recalcification times were measured using a Kugel-koagulometer (ABW Medizin und Technik GmbH) in 50 μl human or murine (WT or F12 − / − ) PRP. .. Human PRP was preincubated with Trap6 (30 μM), Horm's collagen (33 μg ml −1 ) or buffer and murine PRP was preincubated with Ca 2+ ionophore (A23187, 5 μM), collagen (33 μg ml −1 ) or buffer at 37 °C for 10 min in the absence or presence of freshly purified PPX, PPX_Δ12 (500 μg ml −1 each) or |